2 blue chip ASX 200 shares rated as buys

Ramsay Health Care Limited (ASX:RHC) and this blue chip ASX 200 share could be in the buy zone. Here's why they are highly rated…

| More on:
A compass with the word opportunities is shown in black and blue representing a broker upgrade on the EML share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you wanting to boost your portfolio with some blue chip ASX 200 shares in May?

Then you might want to take a look at the blue chips listed below. Here's what you need to know about them:

Goodman Group (ASX: GMG)

The first blue chip ASX 200 share to look at is Goodman Group. It is a leading integrated commercial and industrial property company with a growing portfolio of warehouses, large scale logistics facilities, and business and office parks. 

Goodman Group has been growing at a consistently solid rate over the last few years. This has been driven by its successful strategy of investing in and developing high quality industrial properties in strategic locations.

Positively, this strong form has continued in FY 2021. In fact, just this morning the company released its third quarter update and revealed further solid growth.

As a result, management believes it is on course to achieve its FY 2021 guidance for operating profit of $1.2 billion and earnings per share growth of 12%.

One broker that is positive on the company is Citi. It currently has a buy rating and $21.00 price target on its shares.

Ramsay Health Care Limited (ASX: RHC)

Another ASX 200 blue chip share to look at is Ramsay Health Care. It is a leading private healthcare company with operations across the world.

Ramsay has been battling tough trading conditions over the last 12 months due to the pandemic. And while things are still not entirely back to normal, it has returned to growth in the ANZ market.

Looking ahead, the company looks well-placed to benefit from a backlog in surgeries in the near term and increased demand for healthcare services over the long term. 

In addition to this, the company has a strong balance sheet and the option of accelerating its growth through expansions and acquisitions.

Earlier this week Goldman Sachs retained its conviction buy rating and $75.00 price target on the company's shares. Its analysts are positive on its outlook and continue to expect Ramsay to outperform the market's expectations in FY 2021 and FY 2022.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

A happy older couple relax in a hammock together as they think about enjoying life with a passive income stream.
Blue Chip Shares

Buy these quality ASX blue chip shares for a passive income boost

Analysts think these blue chips could be great options for investors searching for passive income.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

3 excellent ASX 200 blue chip shares to buy in 2025

Analysts have good things to say about these blue chips.

Read more »

A fit man flexes his muscles, indicating a positive share price movement on the ASX market
Blue Chip Shares

3 strong ASX 200 blue chip stocks to buy with $2,000 in December

These blue chips have been given the thumbs up from analysts.

Read more »

A share market analyst looks at his computer screen in front of him showing ASX share price movements
Blue Chip Shares

Analysts name 3 strong blue chip ASX 200 shares to buy in December

Let's see which blue chips are bring tipped as buys by analysts right now.

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Blue Chip Shares

Buy these 3 high-quality ASX 200 blue chip shares in December

Analysts think these high-quality shares are buys right now. Let's see what they are saying.

Read more »

Two people comparing and analysing material.
Blue Chip Shares

Are Woodside or CBA shares a better buy?

Here’s how I’d compare these two major ASX blue chips.

Read more »

A group of young people lined up on a wall are happy looking at their laptops and devices as they invest in the latest trendy stock.
Blue Chip Shares

Why these ASX 200 blue chip shares could generate big returns

Brokers think these shares are could be dirt cheap at current levels.

Read more »

Man sits smiling at a computer showing graphs
Blue Chip Shares

3 ASX shares Australians can buy and hold for the next decade

Analysts think these high quality stocks could be in the buy zone right now.

Read more »